Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.23.3
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Stock Options    
Unvested, beginning balance outstanding (in shares) 700,729  
Granted (in shares) 18,796  
Exercised (in shares) 0  
Vested (in shares) (175,175)  
Forfeited (in shares) 0  
Unvested, ending balance outstanding (in shares) 544,350 700,729
Vested not exercised (in shares) 175,175  
Weighted-Average Grant Date Fair Value    
Unvested, beginning balance outstanding (in dollars per share) $ 4.5  
Granted (in dollars per share) 5.3  
Exercised (in dollars per share) 0  
Vested (in dollars per share) 4.5  
Forfeited (in dollars per share) 0  
Unvested, ending balance outstanding (in dollars per share) 4.5 $ 4.5
Vested not exercised (in dollars per share) $ 4.5  
Weighted Average Remaining Contractual Life (in years) 8 years 7 months 6 days 9 years 9 months 18 days
Weighted average remaining contractual life, granted (in years) 9 years 6 months  
Weighted average remaining contractual life, vested (in years) 8 years 6 months  
Weighted average remaining contractual life, vested not exercised (in years) 8 years 6 months  
Granted Intrinsic value $ 0.2  
Vested Intrinsic value 1.2  
Intrinsic value 0 $ 0.2
Vested not exercised, intrinsic value $ 1.2